Therapy News and Research

RSS

Celebrex safe for osteoarthritis

According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.

1 Mar 2006

For some with partial spinal cord injury, two different therapies show positive results

Body weight-supported treadmill training isn't more effective than conventional mobility rehabilitation for restoring movement to those with partial spinal cord injury, according to a new study.

28 Feb 2006

Link between rheumatoid arthritis and cancer examined

Rheumatoid arthritis is an inflammatory disease of the immune system and is thought to be linked to an increased risk of cancers of the lymphatic system.

28 Feb 2006

senSAVE offers 24-hour telemedicinal health care

senSAVE is a radio networked monitoring system of intelligent sensors. The sensors for wireless ECG data recording are integrated into a shirt.

27 Feb 2006

Clinical trial of new Bionovo menopause drug moves forward

Today, millions of women suffer from often-harsh symptoms of menopause such as hot flashes and night sweats -- and relief is nowhere to be found.

27 Feb 2006

New FDA approved mobile electron-beam system increases survival rates of women with advanced rectal cancer

Colorectal cancer is widely considered a man's disease, but actually affects an equal number of women and men. Detected early, it is highly curable in both genders, with survival rates approaching 90 percent. But if the cancer is detected at a more advanced stage, the outlook is often dismal.

27 Feb 2006

Study shows survival advantage for men treated with radical prostatectomy or radiation therapy compared to observation

A new study shows older men with early stage prostate cancer survive longer if they are treated versus not being treated in favor of the "watchful waiting" approach advocated by many physicians for older men with other health problems.

27 Feb 2006

Oral agent alendronate may help men with prostate cancer suffering from bone loss

Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis, according to a study presented by the University of Pittsburgh Medical Center (UPMC) at the American Society of Clinical Oncology Prostate Cancer Symposium, Feb. 24 to 26 at the San Francisco Marriott.

27 Feb 2006

Androgen deprivation therapy does not prevent prostate cancer from spreading

Oregon Health & Science University Cancer Institute researchers wanted to know if depriving men of testosterone actually keeps cancer from spreading beyond the prostate.

27 Feb 2006

New tool to discover molecules that can enhance or block different kinds of tastes

Researchers from the Monell Chemical Senses Center have succeeded in growing mature taste receptor cells outside the body and for the first time have been able to successfully keep the cells alive for a prolonged period of time.

27 Feb 2006

Teatments based on behaviour could reduce prescription drug use

New psychological treatments - behavioural medicine - could significantly reduce the need for drug treatments for some conditions, cutting health system costs says an editorial in this week's British Medical Journal.

27 Feb 2006

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

A second course of methotrexate, the most commonly used drug to treat rheumatoid arthritis, is effective in nearly half of studied patients for whom a previous treatment with the drug was ineffective.

27 Feb 2006

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.

27 Feb 2006

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

An inflammatory disease of the immune system, rheumatoid arthritis (RA) is associated with increased occurrence of lymphoma--or cancers of the lymphatic system, which plays an integral role in the body's ability to fight infection.

27 Feb 2006

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

Offering hope for millions of people who suffer the most from osteoarthritis, a study published in the New England Journal of Medicine (NEJM) has found that the combined use of two dietary supplements - glucosamine and chondroitin - provided significant pain relief from the most common form of arthritis.

24 Feb 2006

$1 million of mesothelioma research funding

The Mesothelioma Applied Research Foundation (MARF) has announced awards of almost $1 million in additional research funding aimed at curing mesothelioma.

24 Feb 2006

Telemetry captures stroke patients' cardiac problems

To detect "silent" or new cardiac abnormalities, all patients hospitalized for stroke should receive continuous cardiac rhythm monitoring (telemetry) for at least the first 24 hours after the stroke is detected, according to a Loyola University Health System study presented at the American Stroke Association's International Stroke Conference 2006.

24 Feb 2006

Research points to a novel approach to treating serious Strep infections

Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered that so-called flesh-eating "Strep" bacteria use a specific enzyme to break free of the body's immune system, a finding which could potentially lead to new treatments for serious infections in human patients.

24 Feb 2006

Statins lessen heart attack risk

For patients with undiagnosed heart disease, taking medications known as statins and beta-blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain.

24 Feb 2006

PET and MR imaging reveals white matter degeneration in Huntington's

Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers - within the context of an Italian-British collaboration - discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease - particularly in the brain's white matter - an area not previously considered primarily involved with the disease.

24 Feb 2006

Therapy News and Research

Celebrex safe for osteoarthritis

For some with partial spinal cord injury, two different therapies show positive results

Link between rheumatoid arthritis and cancer examined

senSAVE offers 24-hour telemedicinal health care

Clinical trial of new Bionovo menopause drug moves forward

New FDA approved mobile electron-beam system increases survival rates of women with advanced rectal cancer

Study shows survival advantage for men treated with radical prostatectomy or radiation therapy compared to observation

Oral agent alendronate may help men with prostate cancer suffering from bone loss

Androgen deprivation therapy does not prevent prostate cancer from spreading

New tool to discover molecules that can enhance or block different kinds of tastes

Teatments based on behaviour could reduce prescription drug use

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

$1 million of mesothelioma research funding

Telemetry captures stroke patients' cardiac problems

Research points to a novel approach to treating serious Strep infections

Statins lessen heart attack risk

PET and MR imaging reveals white matter degeneration in Huntington's

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News